Insights with Goldman Sachs Part 4: The impact of the Inflation Reduction Act
How will the Inflation Reduction Act impact biopharma? What about the loss of patent exclusivity and its impact on product priorities? Will the increased scrutiny on M&A by the Federal Trade Commission slow down deal making? Hear what our panelists had to say on the topics, including Jerry Lee, Partner of Global Healthcare Investment Banking Group at Goldman Sachs and Lyla Bibi, Managing Director and Head of Americas Healthcare Equity Capital Markets at Goldman Sachs.
Disclaimer: The views and opinions that the panelists express are their own and are for informational purposes only. They do not constitute a recommendation by Goldman Sachs Asset Management for you to take any action. This video includes the perspectives of Amy McKee, our previous Chief Medical Officer & Global Head, Oncology Center of Excellence. Amy left Parexel in August 2024.
Related Insights
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Video
Insights with Goldman Sachs Part 6: Generating investor interest
Jan 26, 2024
Video
Insights with Goldman Sachs Part 1: Future predictions
Jan 26, 2024
Video
Insights with Goldman Sachs Part 2: How pharma is using M&A for growth and innovation
Jan 26, 2024
Video
Insights with Goldman Sachs Part 3: Regulatory dynamics and research trends
Jan 26, 2024